(2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obes Metab. http://doi.org/10.1111/dom.15220
. P. Vestergaard
First name
P.
Last name
Vestergaard
(2022). The incidence of fractures at various sites in newly treated patients with type 2 diabetes mellitus. Bone Rep, 17, 101614. http://doi.org/10.1016/j.bonr.2022.101614
. (2011). The risk of fracture in patients with multiple sclerosis: the UK general practice research database. J Bone Miner Res. http://doi.org/10.1002/jbmr.418
. (2012). A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis. Neurology. http://doi.org/10.1212/WNL.0b013e318266faae
. (2013). Risk of fracture with thiazolidinediones: an individual patient data meta-analysis. Front Endocrinol (Lausanne). http://doi.org/10.3389/fendo.2013.00011
. (2018). Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in Northern Denmark. BMJ Open. http://doi.org/10.1136/bmjopen-2017-018898
. (2020). Use of Sodium-Glucose Co-Transporter-2-Inhibitors (SGLT2-Is) and Risk of Lower Limb Amputation. Curr Drug Saf. http://doi.org/10.2174/1574886315666200805103053
. (2021). The pattern of incident fractures according to fracture site in people with T1D. Osteoporos Int. http://doi.org/10.1007/s00198-021-06175-z
. (2021). Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer. Diabet Med. http://doi.org/10.1111/dme.14725
. (2021). Incidence, hospitalization and mortality and their changes over time in people with a first ever diabetic foot ulcer. Diabet Med. http://doi.org/10.1111/dme.14725
.